Guardian Pharmacy Services, Inc.
GRDN
$33.66
-$0.43-1.26%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.19% | 108.04% | -43.02% | 33.16% | -0.62% |
| Total Depreciation and Amortization | 11.41% | 16.90% | 12.62% | 10.86% | 9.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.59% | -95.56% | 274.41% | -37.82% | 133.46% |
| Change in Net Operating Assets | 309.27% | 125.54% | -105.91% | 83.70% | -106.30% |
| Cash from Operations | 54.90% | 1,401.71% | -31.57% | 102.80% | 53.48% |
| Capital Expenditure | 6.09% | -1.56% | -41.27% | -57.23% | -62.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 78.00% | -80.47% | 12.92% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -90.55% | -7.98% | 18.72% | 176.60% | -92.14% |
| Cash from Investing | 28.89% | -26.62% | 0.76% | -54.11% | -477.51% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 97.60% | 97.98% | 98.17% | 97.86% | 35.39% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 110.53% | 100.13% | 73.01% | 54.90% | 29.55% |
| Cash from Financing | 98.43% | -103.41% | 85.58% | 52.68% | -263.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.47% | -50.48% | 253.23% | 1,715.74% | -24,955.73% |